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Abstract
CpG DNA methylation is one of the main epigenetic modifications playing a role in the control of gene expression. For DNA
viruses whose genome has the ability to integrate in the host genome or to maintain as a latent episome, a correlation has
been found between the extent of DNA methylation and viral quiescence. No information is available for Parvovirus B19, a
human pathogenic virus, which is capable of both lytic and persistent infections. Within Parvovirus B19 genome, the
inverted terminal regions display all the characteristic signatures of a genomic CpG island; therefore we hypothesised a role
of CpG dinucleotide methylation in the regulation of viral genome expression. The analysis of CpG dinucleotide
methylation of Parvovirus B19 DNA was carried out by an aptly designed quantitative real-time PCR assay on bisulfite-
modified DNA. The effects of CpG methylation on the regulation of viral genome expression were first investigated by
transfection of either unmethylated or in vitro methylated viral DNA in a model cell line, showing that methylation of viral
DNA was correlated to lower expression levels of the viral genome. Then, in the course of in vitro infections in different
cellular environments, it was observed that absence of viral expression and genome replication were both correlated to
increasing levels of CpG methylation of viral DNA. Finally, the presence of CpG methylation was documented in viral DNA
present in bioptic samples, indicating the occurrence and a possible role of this epigenetic modification in the course of
natural infections. The presence of an epigenetic level of regulation of viral genome expression, possibly correlated to the
silencing of the viral genome and contributing to the maintenance of the virus in tissues, can be relevant to the balance and
outcome of the different types of infection associated to Parvovirus B19.
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Introduction
Parvovirus B19 (B19V) is a human pathogenic virus, member
of the Erythrovirus genus in the Parvoviridae family [1].
Infection is widespread and can be associated with an ample
range of pathologies and clinical manifestations, whose charac-
teristics and outcomes depend on the interplay between the
virus, the physiological and immune status of the infected
individuals and the development of a virus-specific host immune
response [2,3]. The virus shows a selective tropism for erythroid
progenitor cells in the bone marrow, exerting a cytotoxic effect
and causing a block in erythropoiesis that can manifest as
transient or persistent erythroid aplasia [4]. The virus can be
transmitted to the fetus, where infection of erythroid progen-
itors, fetal cardiac myocytes and placental endothelial cells can
lead to hydrops fetalis and/or fetal death [5]. Common
manifestations of B19V infection are erythema infectiosum in
children or post-infection arthropathies mainly in adults,
however infection has been implicated in a growing spectrum
of other different pathologies affecting diverse tissues and
organs, also including a possible involvement in autoimmune
diseases [6]. Following primary infection, a characteristic of the
virus is its ability to persist in tissues of different origins, mainly
bone marrow, liver, heart, synovia and skin, and constituting the
so-called bioportfolio [7].
Structural features of B19V are common to viruses in the family
[8]. One molecule of linear single-stranded DNA of either positive
or negative polarity, about 5600 bases in length, is encapsidated in
isometric virions, approximately 25 nm in diameter. The viral
genome is composed of a unique internal region, containing all the
coding sequences, flanked by two inverted, repeated terminal
regions (ITR). Terminal regions are 383 nt. long, the distal 365
forming an imperfect palindrome [9,10] able to fold in double-
stranded hairpin structures that are effective as origins of
replication of the viral genome [11,12]. Expression is driven by
the activity of a single promoter proximal to the left end terminal
region, then a series of splicing and cleavage/polyadenylation
events leads to the production of a full set of viral mRNAs coding,
among others, for a viral NS protein and capsid proteins VP1 and
VP2 [13,14]. Functional analysis of the viral genome indicates that
transcription and replication are interrelated and that B19V
genome can be considered a single, two state functional unit
[15,16]. In such model, onset of transcription directly leads to the
production of a full ensemble of viral mRNAs and to replication of
the viral genome, which in turn ensures the achievement of a
productive replicative cycle.
A productive replicative cycle mainly occurs in erythroid
progenitor cells, requiring erythropoietin stimulation [17], while
in other cell types replication can be severely restricted [18,19]. In
such cases, possible levels of restriction to viral replication can be
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33316the conversion of the parental single-stranded genome into a
double-stranded replicative intermediate [18], as well as the
effectiveness of the cellular machinery in assisting viral DNA
transcription or replication [19]. The unique viral promoter is
generic, interacts with cellular factors such as Sp1 and Sp3 and the
viral protein NS as transactivator [20,21], and its activity can be
detected in several cell types although is stronger in erythroid
progenitors. While it is assumed that viral replication depends on
cellular S-phase, it is emerging that expression of the viral genome
has itself effects on the expression of cellular factors modulating
cell cycle progression [22]. A role in the regulation of the viral
replicative cycle can possibly be played by interrelated epigenetic
mechanisms active in eukaryotic cells [23], such as DNA
methylation, or complexing of the viral genome into nucleosomes,
with consequent effects due to nucleosome positioning and histone
modifications.
Epigenetic mechanisms, and in particular the impact of cytosine
methylation at CpG dinucleotides on the viral life cycle have been
mainly studied for viruses that can establish latency and undergo
reactivation, such as viruses in the Herpesviridae family, or for
viruses that can integrate their genome into the host genome such
as Retroviridae or Papillomaviridae. In general, a correlation has
been found between the extent of CpG dinucleotides methylation
of viral genomes and viral quiescence [24]. Scarce information is
on the contrary available on the possible occurrence and role of
methylation for actively replicating viruses, and in particular for
single-stranded DNA viruses such as viruses of the Parvoviridae
family. Parvovirus B19 possesses a complex lifestyle, combining
features of both lytic and persistent infections, making it an
attractive model for the study of epigenetic levels in the regulation
of virus-host interactions.
In the present work, investigation was focused on the
occurrence and role of CpG dinucleotides methylation in the
DNA of Parvovirus B19 and on a possible epigenetic level of
regulation of viral genome expression. In our experimental
scheme, the effects of CpG methylation of viral DNA were first
investigated by transfection of unmethylated or in vitro methylated
viral DNA in a model cell line, then its presence and possible
effects assessed in the course of a prolonged in vitro infection in
different cellular environments. Finally, the presence of CpG
methylation was documented in viral DNA obtained from bioptic
samples, indicating the occurrence of this epigenetic modification
in the course of natural infections.
Methods
Bioinformatic analysis
Parvovirus B19 genome sequence was analysed for the presence
and distribution of CpG dinucleotides by means of EMBOSS
CpGPlot, a web-based program available at EMBL-EBI [25].
Submission consisted of a consensus sequence of B19 genome,
genotype 1, using standard parameters (Window length 100, Obs/
Exp CpG ratio 0.6, Min C+G 50%, Min Length 200).
Plasmid DNA and in vitro DNA methylation
The plasmid clone pB19-M20, generated as a complete
genomic clone from J35 virus source (GenBank ID: AY386330),
was previously described [26] and is a kind gift of Kevin Brown.
The full-length clone pB19-M20 was digested with SalI-HF (New
England Biolabs) to release the B19V genome insert from the
vector and the DNA fragments were separated by agarose gel
electrophoresis. The 5.6 Kb B19V genome was excised and
purified by using the Wizard SV Gel and PCR Clean-Up System
(Promega). The plasmid clone pEGFP-P6 has been constructed by
PCR amplification of the segment between nt. 233 and 582, using
RE modified primers, and cloning in pEGFP-1 (Invitrogen) as an
XhoI-BamHI insert. pEGFP-P6 plasmid DNA was then linearized
by XhoI, dephosphorylated by alkaline phosphatase treatment,
and cleaved by BamHI to release the B19V insert, containing the
viral P6 promoter, from the vector backbone, containing the
EGFP reporter gene (all enzymes from New England Biolabs).
DNA fragments were separated by agarose gel electrophoresis,
excised and purified as described. Following in vitro methylation
of either B19V insert or vector backbone (as described below),
methylated or unmethylated DNA segments were ligated in
different combinations (T4 DNA Ligase, New England Biolabs).
Linear products consisting of the viral promoter religated
upstream of the reporter gene were separated by agarose gel
electrophoresis, excised and purified as described.
Excised B19V DNA, pEGFP-P6 plasmid DNA and viral
promoter insert and vector backbone from pEGFP-P6 underwent
in vitro methylation with CpG methyltransferase (M.SssI; New
England Biolabs). An amount of 1 mg of target DNA was twice
treated with 4 units of M.SssI enzyme for 2 hours at 37uCi na
20 ml reaction volume containing 1.6 mM of S-adenosylmethio-
nine and NEBuffer 2. Enzyme inactivation was carried out by
treatment at 65uC for 20 min. Methylase treated DNA was
purified by using the Wizard SV Gel and PCR Clean-Up System
(Promega). DNA was modified by bisulfite treatment, using the
MethylCode
TM Bisulfite Conversion Kit (Invitrogen) following the
manufacturer’s instructions. Successful methylation (min. 99%
methylation of CpG dinucleotides) and complete conversion
following bisulfite treatment was confirmed by using methyla-
tion-specific Real Time PCR assay and sequencing (see below).
Bisulfite Specific and Methylation Specific Real Time PCR
PCR primers were specifically designed to amplify unmethy-
lated or methylated bisulfite-modified B19 DNA, but not
unmodified DNA. BSP (bisulfite specific PCR) primers amplify
bisulfite-converted sequences independently of the methylation
status, MSP (methylation specific PCR) primers selectively amplify
bisulfite-converted sequences depending on the previous CpG
methylation status (Table 1).
For real-time PCR, bisulfite-modified or native DNA was
amplified by using QuantiTect SYBR Green PCR Kit (Qiagen)
containing a final concentration of 0.5 mM of each primer in a
final volume of 20 ml. The PCR was performed using the
RotorGene 3000 system (Corbett Research) with a 95uC
activation step for 15 min; 95uC for 30 sec, 57uC for 30 sec and
72uC for 15 sec, coupled to signal acquisition, for 40 cycles. Melt
of the PCR product was performed from 60 to 90uC, rising in
0.5uC increments, waiting for 30 sec at the first step and for 5 sec
at each step thereafter, and acquiring the fluorescence at each
temperature increment. Fluorescence emission was recorded in the
FAM/Sybr channel of the instrument and analyzed by using the
quantitation functions available in the RotorGene 6.0 software.
Melting analysis was used for the determination of the specificity of
the amplification products by defining, for each reaction, the
melting profile and the Tm of the products; specific accumulation
of the amplification products was also confirmed by agarose gel
electrophoretic analysis.
Transfection and Infection Experiments
Cells. UT7/EpoS1 cells, kindly obtained form K.Sugamura
[27], were cultured in IMDM (Cambrex), supplemented with 10%
FCS and 2 U/ml Epo, at 37uC and 5% CO2. U937 cells [28],
obtained from LGC Standards (Italy), were cultured in RPMI
(Cambrex) supplemented with 10% FCS. Cells were kept in
Parvovirus B19 DNA Methylation
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5–1610
6 cells/ml, and used for
both transfection and infection experiments when at a density of
3610
5 cells/ml.
Transfection. Transfection of UT7/EpoS1 cells was
performed by using the Amaxa Nucleofector II system (Lonza),
using Nucleofector Reagent R and setting the program T20. An
amount of 1610
6 cells was transfected with 1 mg of test DNA.
Following transfection, the cells were incubated at 37uCi n
complete medium at an initial density of 10
6 cells/ml. Constant
volumes of cell cultures, corresponding to 0.5 ml of the initial cell
culture volume, were collected at different time points from 2 to
72 hours post-transfection (hpt) for nucleic acid purification and
analysis.
Infection. For infection, both UT7/EpoS1 and U937 cells
were incubated at a density of 10
7 cells/ml in minimal medium in
the presence of a reference viremic serum, in order to obtain a
multiplicity of infection of 10
3 geq/cell. Following adsorption for
2 h at 37uC, the inoculum virus was washed and the cells were
incubated at 37uC in complete medium at an initial density of 10
6
cells/ml. Constant volumes of cell cultures, corresponding to
0.5 ml of the initial cell culture volume, were collected at different
time points from 0 to 3 days post-infection (dpi). Thereafter,
equivalent volumes of cell cultures were harvested at three days
intervals post-infection (6–48 dpi), every time before adding three
time volumes of fresh culture medium to support cellular growth.
Nucleic acid purification. Cell culture samples, collected at
the different time points following transfection or infection, were
divided in aliquots each corresponding to 1610
5 cells for
transfection and 5610
5 for infection experiments, then
centrifuged at 12000 g for 2 min. Pelleted cells were processed
both by using the QIAamp DNA Mini Kit (Qiagen), in order to
obtain a total nucleic acid fraction, and by using the ToTally RNA
purification kit (Ambion), in order to obtain a nucleic acid fraction
enriched in RNA. For methylation analysis, purified DNA was
bisulfite modified by using the MethylCode
TM Bisulfite
Conversion Kit (Invitrogen) following the manufacturer’s
instructions.
Quantitative PCR analysis
Standards and Primers. Standard targets for the
amplification reactions were obtained from plasmid pHR0 [29],
that contains an insert corresponding to the complete internal
region of B19 virus genome (nt. 345–5245). Primers for the
amplification of viral targets were the pair R2210–R2355, able to
amplify viral DNA and total viral RNA [15,16]. For normalisation
with respect to the number of cells, a target sequence in the region
of genomic 18S rDNA was selected and amplified by using the
primers 18Sfor (CGGACAGGATTGACAGATTG) and 18Srev
(TGCCAGAGTCTCGTTCGTTA). Oligonucleotides were
obtained from MWG Biotech.
Quantitative real-time PCR. For the quantitative analysis
of viral DNA, an aliquot of the total nucleic acid fraction,
corresponding to 0.1 volumes of experimental samples, was
directly amplified, while for the analysis of methylation status of
viral DNA, an aliquot corresponding to 0.2 volumes of
experimental samples was first processed by bisulfite treatment,
then amplified in parallel amplification reactions for determination
of methylated or unmethylated fractions. For the quantitative
analysis of viral RNA, an aliquot of the RNA enriched fraction
corresponding to 0.1 volumes of experimental samples was first
treated with Turbo DNAfree reagent (Ambion) and then
amplified. Quantitative real-time PCR and RT-PCR were
carried out by using the RotorGene 3000 system (Corbett
Research) and SybrGreen detection of amplification products.
Amplification reactions were performed by using QuantiTect
PCR SybrGreen PCR Kit (Qiagen) or QuantiTect SybrGreen
RT-PCR Kit (Qiagen), including 10 pmol of each specific primer
pair. For PCR, thermal profile consisted in 15 min at 95uC, then
40 cycles of 15 sec at 95uC, 30 sec at 55uC, and 30 sec at 72uC
coupled to signal acquisition. For RT-PCR, two parallel reactions
were performed for each sample, either including (RT+)o r
omitting (RT2) the reverse transcriptase from the reaction mix,
and performing an initial step consisting in 30 min at 50uC, before
the amplification reaction with a standard thermal profile. A final
melting curve was performed, with thermal profile ramping from
60uCt o9 0 uC rising in 0.5uC increments, waiting for 30 sec at the
first step and for 5 sec at each step thereafter, and acquiring the
fluorescence at each temperature increment. Quantitation of total
viral DNA, of methylated/unmethylated fractions of viral DNA,
and of total viral RNA was obtained by the absolute quantitation
algorithm, using calibration curves obtained from respective
standard targets and normalized by the amount of rDNA.
Biological specimens
Two groups of bioptic samples were analysed. One group
included 14 samples, obtained from routine diagnostic analysis,
previously proved positive for the presence of B19V DNA [29],
with productive infection documented by in situ hybridisation for
the detection of viral nucleic acids and indirect immunofluores-
cence for the detection of viral capsid proteins [18]. Another group
included 11 skin biopsies harbouring B19V DNA, without any
evidence of productive viral infection.
Bioptic samples were processed for DNA extraction by using the
QIAamp DNA Mini Kit (Qiagen). For the determination of the
amount of viral DNA, an aliquot of the total nucleic acid fraction,
corresponding to 0.1 volumes of experimental samples, was
Table 1. Primers for bisulfite specific and methylation specific PCR.
Primer Sequence (59-39) Sense Target
0218 GTTGGTTTAGAGTTAATTTTAATTT forward common to bisulfite-modified DNA
0350 UnMet ACCAATCACCACCAATAAACA reverse specific for unmethylated bisulfite-modified DNA
0350 Met GCCGATCGCCGCCGATAAACG reverse specific for methylated bisulfite-modified DNA
0423 AAATAACTACCCATTTACATAAAAC reverse common to bisulfite-modified DNA
In bold are shown bases selectively matching to bisulfite-modified DNA:
CRT on sense target strand.
GRA on complementary strand.
Primers for bisulfite specific and methylation specific PCR are designed on bisulfite-converted, positive-sense strand of B19V genome and can be common and
independent of CpG methylation status of target (0218, 0423), or be specific for unmethylated or methylated targets (0350 UnMet, 0350 Met).
doi:10.1371/journal.pone.0033316.t001
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status of viral DNA, a maximal amount of 500 ng of purified DNA
underwent bisulfite treatment, then an aliquot corresponding to
0.2 volumes of initial samples was amplified using BSP or MSP
primers as described.
Ethics statement
Clinical samples and data used in this study were available to
our research group as part of the institutional diagnostic service at
the Microbiology Unit, Policlinico S.Orsola-Malpighi, Bologna.
All analysed samples have been sent from the Surgical Pathology
Department of the Policlinico S.Orsola-Malpighi to our laboratory
with a specific request of detection of B19V DNA, and have been
collected, processed, assigned an anonymous code number and
archived according to approved and certified diagnostic protocols.
Investigation described in this study was carried out on archived
residual specimens stored for research use following diagnostic
analysis and, in accordance with the recommendations of the
Ethical Committee of Policlinico S.Orsola-Malpighi, did not
require collection of informed consent. All analysed samples are
anonymous and unlinked from clinical databases, in accordance
with Italian Privacy Law (Decree 196/2003, 1110).
Results
Parvovirus B19 genome and CpG islands
As a basis for investigation, Parvovirus B19 genome sequence
was inspected for the presence and distribution of CpG
dinucleotides by means of EMBOSS CpGPlot, a web-based
program available at EMBL-EBI. Submission of a consensus
sequence of B19V genome, genotype 1, for analysis by CpGPlot
using standard parameters indicated that the inverted terminal
regions (nt. 1–383 and nt. 5214–5596) on the positive sense strand
and the central exon region (nt. 2060–2355) on the complemen-
tary strand present a clustered CpG dinucleotide distribution, a
pattern typical of CpG islands [25] (Figure 1).
Sequence inspection within the left terminal region highlighted
the distribution of CpG dinucleotides (Figure 2). Within a 383 bps
sequence of dyad symmetry, a set of 34 CpG dinucleotide pairs are
present, comprising a cluster at the site of hairpin symmetry (nt.
179–188) and two symmetric clusters at distal positions (nt. 14–28
and 338–352), in addition to other disperse elements within
hairpin. The distal symmetric clusters are close to cis- recognition
sequences, such as Sp1 and Sp3 factors binding sites (classical GC
boxes) [20] and viral NS protein binding elements [21]. Additional
CpG dinucleotides are present outside the left terminal region as
part of the viral promoter, within the transcription start site at nt.
531 (8/148 bps). On the contrary, only sparse CpG dinucleotides
are present in the central exon region (9/274 bps). We therefore
focused our attention on the occurrence of cytosine methylation in
CpG dinucleotides within the left terminal region and its possible
role on regulation of gene expression, investigating the region
between the internal harm of the palindrome and the end of ITR
(nt. 183–383).
Methylation-specific quantitative PCR assay
Analysis of CpG DNA methylation within the selected target
region was carried out by an aptly designed methylation-specific,
quantitative real-time PCR assay on bisulfite-modified DNA.
For validation of the assay, a B19V DNA standard target was
obtained as an excised insert from pB19-M20 plasmid [26] and in
vitro methylated at CpG dinucleotides by means of M.SssI
enzyme. Both native and in vitro methylated DNA were then
subjected to bisulfite treatment, which converts unmethylated C
bases into T, thus originating two noncomplementary strands. All
primers for quantitative PCR, described in Table 1, were
subsequently designed for amplification of the sense strand, and
employed as BSP (bisulfite specific PCR) primer pairs, able to
specifically amplify bisulfite-converted sequences independently of
the methylation status, and as MSP (methylation specific PCR)
primer pairs, used in two different combinations able to selectively
amplify bisulfite-converted sequences depending on the previous
Figure 1. Identification of CpG islands within B19V genome. Analysis of Parvovirus B19 genome sequence for the presence and distribution
of CpG dinucleotides was performed by means of EMBOSS CpGPlot. Submission consisted of a consensus sequence of B19 genome, genotype 1,
using standard parameters (Window length 100, Obs/Exp CpG ratio 0.6, Min C+G 50%, Min Length 200). Results are shown for positive sense (A) and
complementary (B) strands. Upper graphs, distribution of observed/expected ratios of CpG dinucleotides; middle graphs, distribution of C+G; lower
graphs, identification of putative CpG islands according to set parameters. (EMBOSS CpGPlot accessed at http://www.ebi.ac.uk/Tools/emboss/
cpgplot/).
doi:10.1371/journal.pone.0033316.g001
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performance of the BSP and MSP assays was evaluated on serial
dilutions of native and M.SssI methylated pB19-M20 targets,
either untreated or bisulfite-converted, and is reported in Table 2.
BSP assay specifically amplified bisulfite-converted DNA with
respect to untreated, with similar efficiencies independently of the
methylation status, while MSP assay showed selective amplifica-
tion of unmethylated or methylated targets depending on the
primer combinations used. For MSP assay, a quantitative
evaluation of methylated [DNAmet] or unmethylated [DNAunmet]
targets was obtained by direct interpolation on respective
calibration curves. A methylation index was defined as the ratio
of methylated over total DNA [DNAmet/(DNAmet+DNAunmet)], as
a measure of the methylation status on B19V DNA. BSP and MSP
amplification products also showed different melting profiles
indicative of a different base content resulting from preservation
of methylated cytosines following bisulfite treatment, therefore
allowing confirmation of selective amplification of methylated or
unmethylated viral DNA. Finally, BSP amplification products
were sequenced, and the resulting chromatograms both indicated
the complete conversion operated by bisulfite treatment on
unmethylated C bases, and identified the unconverted methylated
C bases in CpG dinucleotides.
CpG DNA methylation and viral genome expression
The effects of the occurrence of CpG methylation of viral DNA
on the viral expression profile was investigated by transfection of
unmethylated or in vitro methylated viral DNA in the UT7/
EpoS1 model cell line, able to support both transcriptional and
replicative activity of a transfected B19V complete genomic insert
[12,26], and subsequent quantitative analysis of viral nucleic acids
in a time course post-transfection. For this purpose, UT7/EpoS1
cells were transfected with 1 mg/10
6 cells of either unmethylated
or M.SssI methylated B19V DNA, previously excised from pB19-
M20 plasmid, using the Amaxa nucleofection system. Constant
volumes of cell cultures, corresponding to 0.5 ml of the initial cell
culture volume, were collected from 2 to 72 hours post-
transfection (hpt). For quantitative analysis of viral nucleic acids,
total DNA and RNA from cell fractions were purified and viral
DNA or RNA were amplified by using previously established
primer pairs and PCR conditions. Purified DNA was bisulfite-
modified, then viral bisulfite-modified DNA was amplified by
using the MSP primer pair for analysis of the methylation status of
viral DNA. Data were analysed by using the quantitation analysis
and melting curve analysis algorithms in the RotorGene 6.0
software, calibrated to standard reference curves.
Results obtained from a quantitative analysis of viral nucleic
acids are reported in Table 3. Transfected unmethylated viral
DNA was not methylated to significant fractions, while transfected
methylated viral DNA was demethylated to a marginal extent,
with a calculated methylation index varying in the range 0.97–
0.93. Transcriptional activity of transfected viral DNA indicated a
possible correlation with the methylation status, as methylated
compared to unmethylated viral DNA showed a 1–1.5 Log
reduction in the ratio of total viral RNA to viral DNA.
A possible role of CpG methylation within the left terminal
region of B19 genome was directly investigated by analysing the
activity of the viral promoter in directing the expression of a
reporter gene. For this purpose, an insert corresponding to the nt.
183–530 of viral DNA and encompassing the viral P6 promoter
was cloned in pEGFP-1 plasmid vector to give the plasmid
pEGFP-P6. Purified plasmid DNA was methylated in vitro at CpG
dinucleotides by means of M.SssI enzyme, then both unmethy-
lated and in vitro methylated DNA were transfected in UT7/
EpoS1 cells as described before, with equal efficiency as
determined by quantitative PCR. The activity of the reporter
gene was determined by microscopic evaluation of EGFP
fluorescence. EGFP expression was observable for unmethylated
but not for methylated pEGFP-P6, suggesting a possible direct
effect of CpG methylation on hampering viral promoter activity
(Figure 3, A–B).
To assess a specific effect of methylation of CpG dinucleotides
within the viral promoter with respect to intragenic CpG
dinucleotides in the EGFP sequence, the B19V insert containing
Figure 2. Presence and distribution of CpG dinucleotides in B19V genome. The left terminal region and the proximal part of the internal
region of B19V genome are shown in the diagram (nt.1–586, scale at the top line). Upper line: thick segment, left terminal region and axis of dyad
symmetry; thin segment, internal region. Middle line: distribution of CpG dinucleotides, TATA box and start of transcription. Lower line: distribution of
cis- recognition sequence elements. NSBE 1–4, NS protein binding elements 1–4 [19]. Sp1/3, Sp factors 1/3 recognition sequences.
doi:10.1371/journal.pone.0033316.g002
Table 2. Analytical characteristics of bisulfite and methylation





Unmethylated BSP 0218-0423 10
2–10
8 1.85 74.80
MSP 0218-0350 UnMet 10
2–10
8 1.84 73.15
MSP 0218-0350 Met .10
8 ––
Methylated BSP 0218-0423 10
2–10
8 1.90 77.00
MSP 0218-0350 UnMet .10
4b – 74.00
b
MSP 0218-0350 Met 10
2–10
8 1.83 76.80
a)bisulfite-treated B19V insert excised from pB19-M20.
b)amplification of residual, unmethylated target following in vitro M.SssI
treatment.
Unmethylated or in vitro methylated, bisulfite-treated B19V inserts from pB19-
M20 plasmid have been quantified spectrophotometrically and 10-fold diluted
to obtain quantitative standards for the definition of calibration curves.
Analytical characteristics have been determined from triplicate amplification of
standards in the range 10
2–10
8 target copies/reaction. For calibration curves, R
2
is .0.99 and CV is 0.16–0.24.
doi:10.1371/journal.pone.0033316.t002
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containing the EGFP reporter gene. Then, DNA fragments were
separately methylated in vitro at CpG dinucleotides by means of
M.SssI enzyme and different combinations of methylated or
unmethylated B19V insert or vector backbone segments were
ligated, yielding linear products consisting of the viral promoter
religated upstream of the reporter gene. Purified ligation products
were transfected in UT7/EpoS1 cells and the activity of the
reporter gene determined as before. EGFP expression was
observable to levels comparable to unmethylated plasmid in the
case of ligated unmethylated viral promoter and vector backbone,
was reduced to minimal levels following methylation of either the
viral promoter or the vector backbone, and was absent when both
of them were methylated (Figure 3, C–F). These results indicate, in
addition to a non-specific effect of intragenic CpG methylation on
gene expression, that methylation of CpG dinucleotides within the
viral promoter can have a direct negative effect on its activity.
CpG DNA methylation in a time course of in vitro
infection
The effects of the presence of methylated CpG dinucleotides in
viral DNA in modulating genome expression profile prompted for
investigation of a possible role of DNA methylation in the course
of infection of model target cells. For this purpose, the occurrence
of CpG DNA methylation in B19V DNA and the possible effects
on the viral expression profile were investigated in a prolonged
course of in vitro infection in two different cell lines, namely,
UT7/EpoS1 cells, chosen as a restrictive model cell system
[15,16], and U937 cells, proposed as a nonpermissive model cell
system [30].
UT7/EpoS1 and U937 cells were infected with a reference
viremic serum at a calculated multiplicity of infection of 10
3 geq/
cell and maintained at an initial density of 10
6 cells/ml. Constant
volumes of cell cultures were collected at daily intervals from 0 to 3
days post-infection, then equivalent volumes of cell cultures were
harvested at three days intervals post-infection until day 48 post-
infection, every time before adding three time volumes of fresh
culture medium to support cellular growth. Quantitative analysis
of viral (unmethylated/methylated) DNA and RNA was then
carried out as described for the transfection experiments.
Results obtained from a quantitative analysis of viral nucleic
acids are reported in Table 4. Input viral DNA was characterized
by a minimal but measurable amount of methylated CpG
dinucleotides, with a calculated methylated index at about 10
24.
In the course of infection, the differences in the viral replicative
cycles were evident and a progressive, differential methylation of
intracellular viral DNA was observed throughout the time course
of infection in the two model cell systems.
In UT7/EpoS1 cells, viral DNA was consistently detected until
day 27, with higher levels indicating viral DNA replication
occurring through days 2–15. Methylation analysis indicated the
presence of low levels of methylated CpG dinucleotides along with
a progressive increase in the fraction of methylated DNA, with a
calculated methylation index ,0.01 for the early time points
increasing to a maximal value of 0.03 at day 27. Viral RNA was
reliably detected until day 24, showing higher levels indicative of a
maximal transcriptional activity occurring through days 1–9.
In U937 cells, viral DNA was also detected until day 27,
however with constantly decreasing amounts indicating absence of
DNA replication. Methylation analysis indicated the presence of
higher levels of methylated CpG dinucleotides compared to UT7/
EpoS1 cells, also in this case with a progressive increase in the
fraction of methylated DNA, leading from a calculated methyl-
ation index of about 0.01 for the early time points, increasing from
Table 3. DNA methylation and quantitative analysis of B19V
nucleic acids in transfection experiments.







02 hpt 1.44E+06 ,0.001 8.32E+05 5.78E201
24 hpt 1.49E+06 ,0.001 3.86E+07 2.60E+01
48 hpt 5.49E+05 ,0.001 1.17E+10 2.13E+04
72 hpt 1.23E+05 ,0.001 1.34E+10 1.09E+05
pB19-M20, Methylated 02 hpt 1.14E+06 0.969 2.42E+04 2.12E202
24 hpt 1.09E+06 0.972 1.99E+06 1.82E+00
48 hpt 1.03E+06 0.955 2.19E+09 2.13E+03
72 hpt 2.56E+05 0.929 1.58E+09 6.18E+03
UT7/EpoS1 cells were transfected with 1 mg/10
6 cells of either unmethylated or
M.SssI methylated B19V DNA, excised from pB19-M20 plasmid, and samples
collected at 2, 24, 48, 72 hours post-transfection (hpt). Quantitative analysis was
carried out for the determination of the amounts of viral DNA and total viral
RNA from cell fractions (copies/10
4 cells). Methylation index was calculated by
parallel amplification with both MSP primer pairs on bisulfite-modified DNA and
is expressed as ratio of methylated over total viral DNA.
doi:10.1371/journal.pone.0033316.t003
Figure 3. CpG methylation and EGFP reporter gene expression
in UT7/EpoS1 cells. Activity of viral P6 promoter, as determined by
direct detection of EGFP fluorescence following transfection in UT7/
EpoS1 cells of: unmethylated (A) or in vitro methylated (B) pEGFP-P6
plasmid DNA; linear products derived from ligation of the viral
promoter (unmethylated, C and E, or methylated, D and F), upstream
of the reporter gene in pEGFP-1 vector backbone (unmethylated, C and
D, or methylated, E and F). Transfected UT7/EpoS1 cells were harvested
at 72 hpt, about 50000 cells were spotted on glass slides, fixed with 4%
paraformaldehyde in PBS, and counterstained with Evans Blue. FITC
filter set, original magnification 406.
doi:10.1371/journal.pone.0033316.g003
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24–27. In U937 cells, viral RNA was not reliably detected over
background levels throughout the time course, indicating absence
of effective transcriptional activity in this nonpermissive cellular
system.
Occurrence of CpG DNA methylation in clinical samples
The presence of CpG DNA methylation in B19V DNA was
investigated in two groups of bioptic samples. One group included
14 samples, obtained from routine diagnostic analysis, previously
proved positive for the presence of B19V DNA, with productive
infection documented by in situ hybridisation for the detection of
viral nucleic acids and indirect immunofluorescence for the
detection of viral capsid proteins. Another group included 11 skin
biopsies harbouring B19V DNA, without any evidence of
productive viral infection.
Within the group of samples obtained from patients with
documented infection (Table 5), 12 samples could be amplified by
using both BSP and MSP primers following bisulfite treatment of
purified DNA. Amplification with both combinations of the MSP
primers indicated the presence of detectable levels of CpG
methylation in a subset of samples. The distribution of the
calculated methylation index for the different samples is reported
in Figure 4 and the distribution of methylated CpG dinucleotides
within the region of interest is reported in schematic diagram form
in Figure 5.
In particular, higher levels of CpG methylation were detected in
endomyocardial tissues obtained from patients with myocarditis.
When available, follow-up samples in these cases indicated both
the persistence of viral DNA and the presence of CpG methylation
at stable levels, in the range 0.14–0.71. As an exception, samples
ML.1 and ML.2, obtained at presentation, characterized by a
similar methylation index of 0.27–0.30, can be compared with
sample ML.3 obtained at +18 days, showing an increasing amount
of viral DNA and undetectable levels of CpG methylation. Such
difference could also be confirmed by sequencing of BSP
amplification products, that showed the presence of partially
protected C bases adjacent to G, as indicative of the occurrence of
CpG methylation, in sample ML.1 but not ML.3. Lower or
undetectable CpG methylation levels were observed in two
placental samples [31] and in a duodenal tissue sample obtained
from a case of acute aplastic crisis [32]. This last sample can be
compared to a pair of intestinal samples from a case of chronic
inflammatory bowel disease with involvement of B19 virus [33],
obtained in the early, active (sample AP.1) and remission (sample
AP.2) phases of disease. For these samples, due to limited amounts
available, we could perform BSP amplification only, however
sequencing of amplification products indicated the occurrence of
CpG DNA methylation in B19V DNA present in tissues obtained
in the later rather than the early phase of infection. Finally, due to
the low amounts of viral DNA, the group of 11 skin bioptic
samples harbouring viral DNA [34] was analysed by using BSP
primers only. Amplification products could be obtained for 4
samples, while readable sequencing was possible for one sample
(S.358, Figure 5), confirming in this case the presence of a fraction
of methylated CpG dinucleotides.
Discussion
DNA methylation at cytosine bases in the context of CpG
dinucleotides is one of the main epigenetic modifications, along
with histone modifications and nucleosome positioning, playing a
role in the control of gene expression. Epigenetic modifications
have been extensively studied as markers of neoplastic processes,
neurological disorders and autoimmune diseases [23]. The role of
epigenetic modifications, in particular CpG methylation, in the
genome of DNA viruses has been the subject of studies concerning
large DNA viruses, whose genome has the ability to integrate in
the host genome or to maintain itself as a latent episome, and can
directly or indirectly be associated with the establishment of
tumorigenic processes [35]. On the other hand, the occurrence
and a possible role of CpG methylation in the genome of small
viruses have not been investigated in detail. In particular, little
information is available on epigenetic modifications of parvoviral
genomes such as AAVs or their derived transduction vectors, and
no information is available regarding the human pathogenic
parvovirus B19 [24].
Among viral genomes, alike the human genome, the frequency
of CpG dinucleotides, specific targets for methylation of cytosine
bases, is lower than expected [24]. In the human genome CpG
dinucleotides cluster in regions, ‘‘CpG islands’’, quite rare (1% of
the human genome) but critically linked to regulation of the gene
expression. Within human parvovirus B19 genome, the inverted
terminal regions constitute about 13% of the genome and are
essential as origin of replication [12], and, for the left ITR, as part
of the unique promoter [36]. The ITRs display all the
characteristic signatures of a genomic CpG island [25], and it
was possible to hypothesise a role of CpG dinucleotide methylation
in the regulation of viral genome expression. In fact, as CpG
methylation is involved in gene silencing and silencing of foreign
Table 4. DNA methylation and quantitative analysis of B19V
nucleic acids in a time course of infection.
Infection Sample B19 DNA Met Index B19 RNA RNA/DNA
UT7/EpoS1 cells 00 dpi 8.63E+04 ,0.001 1.81E+03 2.10E202
01 dpi 1.46E+05 ,0.001 2.23E+08 1.53E+03
03 dpi 1.18E+08 ,0.001 3.46E+05 2.93E203
06 dpi 7.19E+08 0.002 4.04E+06 5.62E203
09 dpi 2.22E+08 0.001 9.80E+06 4.41E202
12 dpi 1.99E+08 0.001 7.95E+05 3.99E203
15 dpi 5.56E+06 0.001 1.33E+05 2.39E202
20 dpi 4.21E+05 0.002 1.85E+04 4.39E202
24 dpi 1.12E+05 0.003 8.46E+03 7.58E202
27 dpi 1.39E+04 0.031 1.29E+02 9.28E203
U937 cells 00 dpi 8.98E+05 0.009 3.79E+03 4.22E203
01 dpi 3.93E+04 0.009 3.68E+03 9.36E202
03 dpi 4.77E+04 0.008 ND ND
06 dpi 2.20E+04 0.013 ND ND
09 dpi 3.85E+05 0.041 1.70E+03 4.42E203
12 dpi 2.16E+05 0.168 ND ND
15 dpi 2.61E+04 0.205 2.49E+03 9.54E202
20 dpi 1.01E+04 0.229 ND ND
24 dpi 3.63E+03 0.336 1.51E+03 4.16E201
27 dpi 2.37E+03 0.423 ND ND
UT7/EpoS1 and U937 cells were infected with B19V at a multiplicity of infection
of 10
3 geq/cell, and samples collected from 0 to 27 days post infection (dpi).
Quantitative analysis was carried out for the determination of the amounts of
viral DNA and total viral RNA from cell fractions (copies/10
4 cells). Methylation
index was calculated by parallel amplification with both MSP primer pairs on
bisulfite-modified DNA and is expressed as ratio of methylated over total viral
DNA. ND: not detected.
doi:10.1371/journal.pone.0033316.t004
Parvovirus B19 DNA Methylation
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33316DNA elements integrating in a host genome [37], CpG
methylation of parvovirus B19 DNA might also be relevant as a
mechanism contributing to silencing of a potentially lytic virus.
Parvovirus B19 has a selective tropism for erythroid progenitor
cells, that can be infected giving rise to a productive infection [38].
In these instances, the virus can replicate in a high proportion of
cells, causing disregulation of cell cycle progression, block of
erythroid differentiation and apoptosis of infected cells [22].
Alternatively, the virus can persist in a variety of tissues, such as
bone marrow, liver, heart, synovia, skin and others, apparently in
a quiescent state [7]. It remains to be determined in what form the
virus persists, whether as cryptic virions or as episomal or possibly
integrating into the host genome, and whether the virus is
functionally impaired, latent with the possibility of reactivation or
persistently replicating at low levels [39]. In vitro, the virus can
also infect a few semipermissive myeloblastoid cell lines, such as
UT7/EpoS1 cells, giving rise to a restrictive pattern of replication
[15,16], while in cell lines such as U937 an abortive pattern of
infection with limited genome expression has been reported [30].
Such two systems can be proposed as models for establishment of
persistence, where a role for epigenetic regulation can be
hypothesised and studied.
In our experiments, we investigated the presence of CpG
dinucleotide methylation by performing analysis of bisulfite-
modified DNA. Sequencing of bisulfite-modified, PCR amplified
viral DNA can be employed for the direct detection of methylated
cytosines within the full sequence of the region of interest, however
this approach has the disadvantage that base representation in the
amplification product is not linear and low-level methylation
might therefore remain undetected. To overcome these limita-
tions, a quantitative methylation specific real-time PCR assay was
developed, achieving a quantitative determination of the methyl-
ation status of specific positions in the viral genome. While not
being a genome-wide technique [40], our approach had the
advantage of a targeted and accurate quantitative determination
and ability to detect minimal frequencies of methylated DNA in
relevant selected positions.
The effect of CpG methylation on viral DNA was initially
assessed on transfected full-length, functionally competent cloned
viral DNA [12,26]. When measuring the degree of methylation of
CpG dinucleotides within the left terminal region of the viral
genome, a contrasting effect was observed, so that absence of
substantial methylation of transfected unmethylated viral DNA
was opposed to a limited but definite extent of demethylation of
transfected methylated viral DNA. This last phenomenon can be a
possible result of the balance between the replicative activity
attributed to transfected viral DNA [26] and the accessibility of
viral DNA to maintenance methylating enzymes, in a process
Figure 4. Detection of CpG methylation in B19V DNA from bioptic samples. A. Distribution of methylation indexes of viral DNA present in
bioptic samples, as calculated by means of MSP assay [DNAmet/(DNAmet+DNAunmet]. B. Melting profiles of the amplification products obtained by
either MSP primer pair, specific for methylated or unmethylated target sequences (shown for standards and samples with methylation index .0.40).
doi:10.1371/journal.pone.0033316.g004
Table 5. CpG DNA methylation in B19V DNA present in
clinical samples.
Sample (Date) Tissue Clinical setting Viral load Met Index
A.29 (07/09/2008) Placenta IUFD 1.36E+03 0.111
GA.1 (06/07/2006) Placenta IUFD 6.33E+06 ,0.001
BE.1 (12/06/2007) Duodenum Aplastic crisis 6.97E+03 0.005
AP.1 (02/03/2005) Ileum IBD ND ND
AP.2 (20/10/2005) Ileum IBD ND ND
CM.1 (15/01/2009) Myocardium Myocarditis 1.08E+03 0.136
CM.2 (18/02/2009) Myocardium Myocarditis 3.17E+02 0.287
FV.1 (19/04/2010) Myocardium Myocarditis 7.62E+03 0.511
ML.1 (21/02/2005) Myocardium Myocarditis 2.43E+02 0.268
ML.2 (23/02/2005) Myocardium Myocarditis 1.06E+03 0.296
ML.3 (09/03/2005) Myocardium Myocarditis 6.09E+04 0.004
MN.1 (08/11/2005) Myocardium Myocarditis 4.00E+03 0.423
MN.2 (23/11/2005) Myocardium Myocarditis 2.33E+03 0.714
MN.3 (04/01/2007) Myocardium Myocarditis 4.76E+03 0.605
Clinical samples, amount of viral DNA present in tissues (genome copies/100 ng
cellular DNA) and analysis of methylation status of viral DNA as determined by
MSP assay. IUFD: intrauterine fetal death; IBD: inflammatory bowel disease; ND:
not determined.
doi:10.1371/journal.pone.0033316.t005
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transcriptional activity of transfected methylated viral DNA can
be compatible with a possible silencing effect of CpG methylation
on viral DNA. In fact, methylation of CpG residues within the left
ITR and viral promoter can have a direct negative effect on the
promoter activity, as determined by evaluation of expression of a
reporter gene under control of viral sequences. Silencing of the
viral promoter might be due to impaired interaction with cellular
transcription factors [41], however, in the context of a complete
viral genome other mechanisms might be involved, for example
impaired interaction with viral NS protein in its transactivator
function, or histone complexing exerting regulatory effects.
In addition to a measurable effect of CpG methylation on the
viral expression profile following transfection experiments, we
could also document the occurrence of CpG methylation and its
possible effects in the course of in vitro infections of model cellular
systems. In particular, we investigated the effects of cytosine
methylation in CpG dinucleotides within the left terminal region
of the viral genome in the course of in vitro infection experiments,
focused on restrictive or nonpermissive environments such as
UT7/EpoS1 and U937 cells, as model systems for the analysis of a
possible epigenetic regulation leading to establishment of persis-
tence. In the restrictive UT7/EpoS1 cells, the progressive loss of
transcriptional and replicative activity of the viral genome was
only at late times correlated to the establishment of low levels of
CpG methylation. In the nonpermissive U937 cells, CpG
methylation was more prominent. In this instance, cells could be
infected giving rise to a non productive replicative cycle, and the
viral genome persisted within cells at low, relatively stable levels
with progressive accumulation of a high proportion of methylated
DNA. We could not detect a measurable expression of the viral
genome, as described by other investigators mainly occurring as a
consequence of antibody-dependent enhancement of infection
[30]. On the contrary, it appeared that absence of viral expression
and genome replication were both correlated to increasing levels of
CpG methylation of viral DNA.
Finally, cytosine methylation in CpG dinucleotides within the
selected target region was also observed in viral DNA present in
bioptic samples obtained from different tissues. This directly
indicates the occurrence of CpG methylation of viral DNA in
infected cells, that can possibly be indicative of the progressive
establishment of persistence of the viral genome in tissues, and
suggests a potential role for epigenetic mechanisms in regulating
the course of natural infections. Further analysis conducted on
larger groups of clinical samples will be required to investigate this
eventuality.
From our experiments, it is possible to hypothesise that viral
DNA, in its active state in the course of productive infections in
permissive cellular environments, is not methylated to a significant
extent, but that the absence of transcriptional and replicative
activity of the viral genome as observed in nonpermissive cellular
environments can be correlated to the progressive methylation of
viral DNA, that in turn may contribute to silencing of the viral
genome and establishment of viral persistence. Viral DNA can
likely be complexed to histons, and be maintained as episome or, a
possibility not experimentally demonstrated so far, may be
integrated in the host genome, as it happens for AAV. These
mechanisms would add possible further levels of epigenetic
Figure 5. Distribution of CpG methylation in B19V DNA from bioptic samples. Representative diagrams derived from sequencing
chromatograms of the amplification products obtained by means of BSP primers on viral DNA from bioptic samples. Top line, schematic diagram of
the left terminal region and proximal part of the internal region of B19V genome, as in Figure 2. BSP and MSP primer positions are indicated. Bottom
lines, diagrams indicating the methylation status of CpG dinucleotides as determined by sequencing of BSP amplification products, for the selected
samples. The relative abundance of methylated or unmethylated cytosines within CpG dinucleotides is indicated by the gray scale code shown at the
bottom of the figure.
doi:10.1371/journal.pone.0033316.g005
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viral DNA from infected cell cultures indicates its maintenance in
episomal form in our experimental setting, whereas the possible
integration of the viral genome into the host cell genome could not
be directly investigated in our bioptic samples.
It should be also recalled that the occurrence of CpG
methylation on viral DNA is also relevant for recognition of
infecting agents operated by the innate immune systems, as
unmethylated viral DNA can be a PAMP recognised by TLR9. A
consensus sequence present in B19 genome interacts with TLR9
and has been shown to inhibit erythroid progenitor cells [42].
Methylation of viral DNA may also contribute to impairment of
pathogenetic potential of the virus and induction of tolerance by
the innate immune systems.
In conclusion, our experiments indicate the presence of an
epigenetic level of regulation of viral genome expression, possibly
linked to the silencing of the viral genome and contributing to the
maintenance of the virus in tissues, a feature typical of
parvoviruses. Further investigation will be needed to confirm
and elucidate in detail the complex network of epigenetic
regulation, involving not only CpG DNA methylation, but also
histone complexing and modifications as well as nucleosome
positioning, in different cellular environments. The picture of
parvovirus B19 as a virus typically capable of lytic, acute infections
has given place to a more complex landscape of a virus capable of
diverse lytic, persistent or even latent/reactivating infections.
Epigenetic regulation, as a viral adaptation to host cells, can be
relevant to the balance and outcome of these different types of
infection.
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